Jun 23 2023 This Week in Cardiology Jun 23 2023 This Week in Cardiology
Starting HF meds during hospitalization for HF, Impella, testosterone, and colchicine are the topics John Mandrola, MD, discusses in this week ' s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 23, 2023 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Low-Dose Colchicine Approved for CVD: Now What? Low-Dose Colchicine Approved for CVD: Now What?
The FDA has given the new low dose of colchicine a broad indication for use in atherosclerotic cardiovascular disease, but how will the drug actually be used in clinical practice?Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 22, 2023 Category: Neurology Tags: Cardiology News Source Type: news
FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease
Inflammation plays a major role in the development of cardiovascular disease (CVD) and has been a missing link in how cardiologists prevent and treat atherosclerotic plaques that can cause heart attacks or strokes. But now, after a priority review, the U.S. Food and Drug Administration (FDA) has…#fda #agephapharmausa #lodoco #cvd #statin #approvalbyfdaoffirst #paulridker #mph #harvardmedicalschool #crp (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2023 Category: Consumer Health News Source Type: news
Colchicine's Rebirth as Cardiovascular Drug Approved by FDA
(MedPage Today) -- The FDA approved colchicine (Lodoco) for cardiovascular prevention in adults with established atherosclerotic disease or multiple risk factors, making it the first anti-inflammatory medicine with such an indication.
The drug... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 20, 2023 Category: American Health Source Type: news
FDA Approves Lodoco (colchicine) as the First Anti-Inflammatory Drug for Cardiovascular Disease
Parsippany, NJ– June 20, 2023– AGEPHA Pharma USA, LLC, today announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco® as the first anti-inflammatory atheroprotective... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 20, 2023 Category: Drugs & Pharmacology Source Type: news
FDA OKs Low-Dose Colchicine for Broad CV Indication FDA OKs Low-Dose Colchicine for Broad CV Indication
The drug represents the first specific anti-inflammatory drug for the reduction of cardiovascular events for patients with established atherosclerotic disease or with multiple risk factors.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 20, 2023 Category: Primary Care Tags: Cardiology News Alert Source Type: news
Colchicine Tied to Lower Incidence of TJA in Coronary Artery Disease
WEDNESDAY, May 31, 2023 -- For patients with chronic coronary artery disease, colchicine is associated with a reduced incidence of total knee replacement (TKR) and total hip replacement (THR) versus placebo, according to a study published online May... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2023 Category: Pharmaceuticals Source Type: news
Low-Dose Colchicine Might Prevent or Delay Knee, Hip Replacements
WEDNESDAY, May 31, 2023 -- An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements.
That ' s the suggestion of a new study finding that older adults who used the drug —... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 31, 2023 Category: General Medicine Source Type: news
Colchicine Price Increase Tied to Poorer Gout Control Over a Decade
WEDNESDAY, May 17, 2023 -- A sharp increase in colchicine prices in 2010 was associated with a sustained decrease in colchicine use and poorer disease control over a decade, according to a study published online May 8 in JAMA Internal Medicine.
Dan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2023 Category: Pharmaceuticals Source Type: news
Colchicine's 2010 Price Spike Had Major Impact on Gout Care Colchicine's 2010 Price Spike Had Major Impact on Gout Care
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 US Food and Drug Administration ruling that enabled a price spike.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Inflammation May Be the Culprit Behind Our Deadliest Diseases
In the early days of my medical residency, I met a man whom we’ll call Jason. He arrived to our emergency room on a holiday, nonchalant yet amiable, and complained of mild chest pain. Jason was tall and trim, with a strong South Boston accent and fingertips still faintly stained from his last home-improvement project. He was only 45 years old, but he looked much younger. He didn’t smoke, barely drank alcohol, and his cholesterol levels had always been normal. No one in his family had a history of heart disease. He asked us if we could work quickly—he wanted to be home for dinner with his daughters.
[time-...
Source: TIME: Health - April 11, 2023 Category: Consumer Health News Authors: Shilpa Ravella Tags: Uncategorized freelance health Source Type: news
Death due to kodalikkizhangu poisoning: a case report - S N, S R, R N.
Deaths due to accidental ingestion, suicidal consumption and homicide poisoning with colchicine alkaloid containing extracts have been documented and reported in innumerable literature across the world. The lowest reported lethal dose of oral colchicine ar... (Source: SafetyLit)
Source: SafetyLit - January 19, 2023 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
Colchicine Use and the Risk of CKD Progression Colchicine Use and the Risk of CKD Progression
A new study examined the effects of colchicine treatment among patients with CKD. What have we learned?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Prednisone, Colchicine Equally Efficacious for CPP Arthritis Prednisone, Colchicine Equally Efficacious for CPP Arthritis
In an open-label, randomized trial, 1 in 5 patients on colchicine had diarrhea, tipping the safety scales in favor of prednisone.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 16, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials
It ' s ' the end of the story for colchicine in COVID-19, ' an expert said. In addition, aspirin does not help outpatients with COVID and a low-dose oral anticoagulant does not improve inpatient outcomes.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 1, 2022 Category: Allergy & Immunology Tags: Cardiology News Source Type: news
